INTERLINK highlights Dr. Richard Freeman, Medical Director and nationally recognized transplant surgeon, whose expertise and passion for quality guide our educational programs and support better outcomes for partners and patients.

INTERLINK began developing its cellular therapy network in 2018 to help manage the high cost of treatments such as CAR-T. Through experienced contracting and comprehensive cost controls, INTERLINK has secured significant discounts, with savings off billed charges sometimes approaching 80%.

Dr. Richard Freeman examines the recent federal shift to a multi-contractor model for the Organ Procurement and Transplant Network. This report analyzes how these regulatory changes and ongoing HRSA staff reductions may impact transplant equity, costs, and the future of the industry.

INTERLINK’s Chief Medical Officer shares highlights from his distinguished career as a pioneering liver transplant surgeon trained under Dr. Thomas Starzl. The interview explores his lifelong commitment to evidence-based care and his instrumental role in developing INTERLINK’s Cancer CARE program.

Mary Braden, a nurse and INTERLINK partner, shares her inspiring personal story of donating a kidney to save a life. This special edition highlights the profound impact of live donation and the exceptional clinical support that guided her through the process.